On the public citation graph

Overview of the New Oral Anticoagulants

https://doi.org/10.1161/atvbaha.115.303397

0 signed · 218 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.

Claim with ORCID

Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.

See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1007/s11239-011-0549-xopenalex-snapshot

Extended-duration rivaroxaban thromboprophylaxis in acutely ill medical patients: MAGELLAN study protocol

inferredcites →https://doi.org/10.1016/j.amjcard.2007.01.052openalex-snapshot

Adjusted Indirect Meta-Analysis of Aspirin Plus Warfarin at International Normalized Ratios 2 to 3 Versus Aspirin Plus Clopidogrel After Acute Coronary Syndromes

inferredcites →https://doi.org/10.1016/j.amjmed.2014.07.024openalex-snapshot

Bleeding Rates in Veterans Affairs Patients with Atrial Fibrillation Who Switch from Warfarin to Dabigatran

inferredcites →https://doi.org/10.1016/j.jacc.2013.03.020openalex-snapshot

Efficacy and Safety of Dabigatran Etexilate and Warfarin in “Real-World” Patients With Atrial Fibrillation

inferredcites →https://doi.org/10.1016/j.jacc.2013.07.104openalex-snapshot

The Effect of Dabigatran Plasma Concentrations and Patient Characteristics on the Frequency of Ischemic Stroke and Major Bleeding in Atrial Fibrillation Patients

inferredcites →https://doi.org/10.1016/s0140-6736(13)62343-0openalex-snapshot

Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials

inferredcites →https://doi.org/10.1056/nejmoa1006885openalex-snapshot

Apixaban versus Enoxaparin for Thromboprophylaxis after Hip Replacement

inferredcites →https://doi.org/10.1056/nejmoa1007432openalex-snapshot

Apixaban in Patients with Atrial Fibrillation

inferredcites →https://doi.org/10.1056/nejmoa1105819openalex-snapshot

Apixaban with Antiplatelet Therapy after Acute Coronary Syndrome

inferredcites →https://doi.org/10.1056/nejmoa1110899openalex-snapshot

Apixaban versus Enoxaparin for Thromboprophylaxis in Medically Ill Patients

inferredcites →https://doi.org/10.1056/nejmoa1112277openalex-snapshot

Rivaroxaban in Patients with a Recent Acute Coronary Syndrome

inferredcites →https://doi.org/10.1056/nejmoa1113697openalex-snapshot

Extended Use of Dabigatran, Warfarin, or Placebo in Venous Thromboembolism

inferredcites →https://doi.org/10.1056/nejmoa1207541openalex-snapshot

Apixaban for Extended Treatment of Venous Thromboembolism

inferredcites →https://doi.org/10.1056/nejmoa1300615openalex-snapshot

Dabigatran versus Warfarin in Patients with Mechanical Heart Valves

inferredcites →https://doi.org/10.1056/nejmp1302834openalex-snapshot

Dabigatran and Postmarketing Reports of Bleeding

inferredcites →https://doi.org/10.1111/j.1365-2710.2010.01162.xopenalex-snapshot

Dabigatran and rivaroxaban for prevention of venous thromboembolism - systematic review and adjusted indirect comparison

inferredcites →https://doi.org/10.1111/jth.12485openalex-snapshot

Effectiveness and safety of novel oral anticoagulants as compared with vitamin K antagonists in the treatment of acute symptomatic venous thromboembolism: a systematic review and meta‐analysis

inferredcites →https://doi.org/10.1111/jth.12605openalex-snapshot

Meta‐analysis of the efficacy and safety of new oral anticoagulants in patients with cancer‐associated acute venous thromboembolism

inferredcites →https://doi.org/10.1111/jth.12823openalex-snapshot

Real‐world variability in dabigatran levels in patients with atrial fibrillation

inferredcites →https://doi.org/10.1160/th13-08-0666openalex-snapshot

A non-interventional comparison of rivaroxaban with standard of care for thromboprophylaxis after major orthopaedic surgery in 17,701 patients with propensity score adjustment

inferredcites →https://doi.org/10.1160/th14-03-0265openalex-snapshot

Insights into the role of thrombin in the pathogenesis of recurrent ischaemia after acute coronary syndrome

inferredcites →https://doi.org/10.1161/atvbaha.114.303396openalex-snapshot

Clinical Experience With the New Oral Anticoagulants for Treatment of Venous Thromboembolism

inferredcites →https://doi.org/10.1161/atvbaha.114.303400openalex-snapshot

Clinical Experience With Novel Oral Anticoagulants for Thromboprophylaxis After Elective Hip and Knee Arthroplasty

inferredcites →https://doi.org/10.1161/atvbaha.114.303401openalex-snapshot

Role of Oral Anticoagulants in Patients After an Acute Coronary Syndrome

inferredcites →https://doi.org/10.1161/circulationaha.113.002332openalex-snapshot

Management and Outcomes of Major Bleeding During Treatment With Dabigatran or Warfarin

inferredcites →https://doi.org/10.1161/circulationaha.114.008828openalex-snapshot

Aspirin for the Prevention of Recurrent Venous Thromboembolism

inferredcites →https://doi.org/10.1161/circulationaha.114.012061openalex-snapshot

Cardiovascular, Bleeding, and Mortality Risks in Elderly Medicare Patients Treated With Dabigatran or Warfarin for Nonvalvular Atrial Fibrillation

inferredcites →https://doi.org/10.1177/1076029614536606openalex-snapshot

Major Bleeding With Dabigatran and Rivaroxaban in Patients With Atrial Fibrillation

inferredcites →https://doi.org/10.1302/0301-620x.94b2.27850openalex-snapshot

Apixaban versus enoxaparin for thromboprophylaxis after hip or knee replacement

inferredcites →https://doi.org/10.7326/0003-4819-143-4-200508160-00005openalex-snapshot

Warfarin plus Aspirin after Myocardial Infarction or the Acute Coronary Syndrome: Meta-Analysis with Estimates of Risk and Benefit

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.3897/pharmacia.73.e197938zenodo-depositor-declared

Cultural adaptation and validation of the Oral Anticoagulation Knowledge Tool in Arabic-speaking Iraqi patients

inferred← citeshttps://doi.org/10.1002/9781119633884.ch60openalex-snapshot

LVAD Clinic: Outpatient Monitoring and Causes for Readmission

inferred← citeshttps://doi.org/10.1002/ange.202108468openalex-snapshot

Controlling Coagulation in Blood with Red Light

inferred← citeshttps://doi.org/10.1002/anie.202108468openalex-snapshot

Controlling Coagulation in Blood with Red Light

inferred← citeshttps://doi.org/10.1002/cmdc.201500319openalex-snapshot

A Bisbenzamidine Phosphonate as a Janus‐faced Inhibitor for Trypsin‐like Serine Proteases

inferred← citeshttps://doi.org/10.1002/cpt.395openalex-snapshot

Genetic testing to guide warfarin dosing: Impact of direct oral anticoagulants

inferred← citeshttps://doi.org/10.1002/gps.5117openalex-snapshot

SSRI co‐medication with NOAC or VKA does not increase hospitalisation for bleeding: A retrospective nationwide cohort study in Austria 2010‐2015

inferred← citeshttps://doi.org/10.1002/pds.4279openalex-snapshot

New oral anticoagulant prescription rate and risk of bleeding in an Italian region

inferred← citeshttps://doi.org/10.1002/pds.5072openalex-snapshot

A descriptive analysis of medicines safety advisories issued by national medicines regulators in Australia, Canada, the United Kingdom and the United States ‐ 2007 to 2016

inferred← citeshttps://doi.org/10.1002/pds.5296openalex-snapshot

Oral anticoagulant therapy and outcome in patients with stroke. A retrospective nation‐wide cohort study in Austria 2012–2017

inferred← citeshttps://doi.org/10.1002/rth2.12015openalex-snapshot

The reversal effect of prothrombin complex concentrate (PCC), activated PCC and recombinant activated factor VII in apixaban‐treated patients in vitro

inferred← citeshttps://doi.org/10.1002/rth2.12121openalex-snapshot

Extended anticoagulation for unprovoked venous thromboembolism

inferred← citeshttps://doi.org/10.1002/rth2.12535openalex-snapshot

Safety of idarucizumab in the reversal of dabigatran at six tertiary care Ontario hospitals

inferred← citeshttps://doi.org/10.1002/rth2.12604openalex-snapshot

Cancer‐Associated ThrOmboSIs – Patient‐Reported OutcoMes With RivarOxaban (COSIMO) – Baseline characteristics and clinical outcomes

inferred← citeshttps://doi.org/10.1002/rth2.12680openalex-snapshot

The edoxaban‐M4 metabolite and measurement of edoxaban by chromogenic assays in human plasma

inferred← citeshttps://doi.org/10.1007/13780_2015_6openalex-snapshot

Venous Thromboembolic Disease in Children and Adolescents

inferred← citeshttps://doi.org/10.1007/5584_2016_113openalex-snapshot

Venous Thromboembolic Disease in Children and Adolescents

inferred← citeshttps://doi.org/10.1007/978-3-030-74462-5_3openalex-snapshot

Pharmacokinetics and Pharmacodynamics of DOAC

inferred← citeshttps://doi.org/10.1007/978-3-030-91483-7_23openalex-snapshot

Comanagement Admission and Timing of Surgery

inferred← citeshttps://doi.org/10.1007/978-3-319-23018-4_40openalex-snapshot

Antithrombotic Treatment in Cirrhosis

inferred← citeshttps://doi.org/10.1007/978-3-319-56782-2_9277-1openalex-snapshot

Novel Oral Anticoagulants

inferred← citeshttps://doi.org/10.1007/978-3-319-57111-9_9277openalex-snapshot

Novel Oral Anticoagulants

inferred← citeshttps://doi.org/10.1007/978-3-662-46689-6_41openalex-snapshot

Pharmaka mit Wirkung auf die Hämostase

inferred← citeshttps://doi.org/10.1007/978-981-15-6739-1_8openalex-snapshot

Hemorrhagic Strokes

inferred← citeshttps://doi.org/10.1007/s00228-017-2374-4openalex-snapshot

Prescribing of NOACs has outnumbered warfarin: exploring how physicians choose anticoagulant treatments

inferred← citeshttps://doi.org/10.1007/s00228-020-03057-xopenalex-snapshot

A case series of the rifampin-warfarin drug interaction: focus on practical warfarin management

inferred← citeshttps://doi.org/10.1007/s00392-018-1408-yopenalex-snapshot

Direct oral anticoagulants and vitamin K antagonists are linked to differential profiles of cardiac function and lipid metabolism

inferred← citeshttps://doi.org/10.1007/s00590-023-03786-6openalex-snapshot

Therapy adherence, safety and efficacy of rivaroxaban in prevention of venous thromboembolism in patients with hip or knee endoprosthesis

inferred← citeshttps://doi.org/10.1007/s00740-021-00420-1openalex-snapshot

Gerinnungswirksame Medikamente im Notfall

inferred← citeshttps://doi.org/10.1007/s10049-020-00763-yopenalex-snapshot

Gerinnungswirksame Medikamente im Notfall

inferred← citeshttps://doi.org/10.1007/s10557-020-07129-zopenalex-snapshot

Identifying the Dominant Contribution of Human Cytochrome P450 2J2 to the Metabolism of Rivaroxaban, an Oral Anticoagulant

inferred← citeshttps://doi.org/10.1007/s11030-024-11024-2openalex-snapshot

Structure-based design and synthesis of novel FXIa inhibitors targeting the S2' subsite for enhanced antithrombotic efficacy

inferred← citeshttps://doi.org/10.1007/s11239-015-1258-7openalex-snapshot

In vitro, antithrombotic and bleeding time studies of BMS-654457, a small-molecule, reversible and direct inhibitor of factor XIa

inferred← citeshttps://doi.org/10.1007/s11239-017-1476-2openalex-snapshot

Real-life experience with the specific reversal agent idarucizumab for the management of emergency situations in dabigatran-treated patients: a series of 11 cases

inferred← citeshttps://doi.org/10.1007/s11239-021-02578-1openalex-snapshot

Effectiveness and safety of the direct oral anticoagulants in non-triple positive antiphospholipid syndrome without prior arterial thromboembolism

inferred← citeshttps://doi.org/10.1007/s12072-021-10247-xopenalex-snapshot

A network meta-analysis of direct oral anticoagulants for portal vein thrombosis in cirrhosis

inferred← citeshttps://doi.org/10.1007/s40264-017-0567-5openalex-snapshot

Safety and Interactions of Direct Oral Anticoagulants with Antiarrhythmic Drugs

inferred← citeshttps://doi.org/10.1016/b978-0-12-409547-2.12433-3openalex-snapshot

Advances in Anticoagulants

inferred← citeshttps://doi.org/10.1016/b978-0-443-27402-2.00027-9openalex-snapshot

Antithrombotic drug—apixaban

inferred← citeshttps://doi.org/10.1016/j.ahjo.2023.100283openalex-snapshot

Bleeding and thrombotic events in bevacizumab-treated patients with colorectal cancer on novel oral anticoagulants and antiplatelet medications

inferred← citeshttps://doi.org/10.1016/j.ajem.2016.09.053openalex-snapshot

Idarucizumab and factor Xa reversal agents: role in hospital guidelines and protocols

inferred← citeshttps://doi.org/10.1016/j.amj.2016.01.001openalex-snapshot

Emergent Bleeding in Patients Receiving Direct Oral Anticoagulants

inferred← citeshttps://doi.org/10.1016/j.amjmed.2016.06.010openalex-snapshot

Idarucizumab and Factor Xa Reversal Agents: Role in Hospital Guidelines and Protocols

inferred← citeshttps://doi.org/10.1016/j.anai.2016.03.012openalex-snapshot

Rivaroxaban-induced leukocytoclastic vasculitis

inferred← citeshttps://doi.org/10.1016/j.asmart.2026.05.002openalex-snapshot

Limited indication of postoperative anticoagulation based on age reduces the incidence of deep venous thrombosis after anterior cruciate ligament reconstruction: A retrospective study

inferred← citeshttps://doi.org/10.1016/j.athoracsur.2020.01.049openalex-snapshot

INVITED COMMENTARY

inferred← citeshttps://doi.org/10.1016/j.bja.2017.11.082openalex-snapshot

Emergency care of patients receiving non-vitamin K antagonist oral anticoagulants

inferred← citeshttps://doi.org/10.1016/j.blre.2018.04.001openalex-snapshot

Plasma contact factors as therapeutic targets

inferred← citeshttps://doi.org/10.1016/j.bmcl.2017.04.008openalex-snapshot

Neutral macrocyclic factor VIIa inhibitors

inferred← citeshttps://doi.org/10.1016/j.bmcl.2019.08.008openalex-snapshot

Structure based design of macrocyclic factor XIa inhibitors: Discovery of cyclic P1 linker moieties with improved oral bioavailability

inferred← citeshttps://doi.org/10.1016/j.bmcl.2020.126949openalex-snapshot

Orally bioavailable amine-linked macrocyclic inhibitors of factor XIa

inferred← citeshttps://doi.org/10.1016/j.ejmech.2024.116501openalex-snapshot

Macrocyclization strategy for improving candidate profiles in medicinal chemistry

inferred← citeshttps://doi.org/10.1016/j.ejvs.2020.11.050openalex-snapshot

Comparing Safety and Efficacy of Rivaroxaban with Warfarin for Patients after Successful Stent Placement for Chronic Iliofemoral Occlusion: A Retrospective Single Institution Study

inferred← citeshttps://doi.org/10.1016/j.healun.2020.01.1329openalex-snapshot

American Association for Thoracic Surgery/International Society for Heart and Lung Transplantation guidelines on selected topics in mechanical circulatory support

inferred← citeshttps://doi.org/10.1016/j.hoc.2016.05.007openalex-snapshot

The Intrinsic Pathway of Coagulation as a Target for Antithrombotic Therapy

inferred← citeshttps://doi.org/10.1016/j.ijcard.2016.03.056openalex-snapshot

Specific antidotes against direct oral anticoagulants: A comprehensive review of clinical trials data

inferred← citeshttps://doi.org/10.1016/j.ijsu.2017.07.031openalex-snapshot

Safety and effectiveness of argatroban versus heparin for preventing venous thromboembolism after lumbar decompressive surgery

inferred← citeshttps://doi.org/10.1016/j.ijsu.2021.02.004openalex-snapshot

Emergency cardiac surgery for patients on NOACs in the NOAC era - Perspective

inferred← citeshttps://doi.org/10.1016/j.jcjq.2017.03.006openalex-snapshot

Designing and Implementing an Electronic Patient Registry to Improve Warfarin Monitoring in the Ambulatory Setting

inferred← citeshttps://doi.org/10.1016/j.jcot.2020.08.005openalex-snapshot

Direct oral anticoagulants (DOACs) and neck of femur fractures: Standardising the perioperative management and time to surgery

inferred← citeshttps://doi.org/10.1016/j.jhep.2017.01.006openalex-snapshot

Anticoagulation in chronic liver disease

inferred← citeshttps://doi.org/10.1016/j.jhep.2019.02.015openalex-snapshot

Current knowledge in pathophysiology and management of Budd-Chiari syndrome and non-cirrhotic non-tumoral splanchnic vein thrombosis

inferred← citeshttps://doi.org/10.1016/j.jmgm.2019.03.017openalex-snapshot

New factor Xa inhibitors based on 1,2,3,4-tetrahydroquinoline developed by molecular modelling

inferred← citeshttps://doi.org/10.1016/j.jtcvs.2019.12.021openalex-snapshot

American Association for Thoracic Surgery/International Society for Heart and Lung Transplantation guidelines on selected topics in mechanical circulatory support

inferred← citeshttps://doi.org/10.1016/j.npg.2021.06.008openalex-snapshot

Oral cavity hematoma: A rare and serious complication of antivitamin K

inferred← citeshttps://doi.org/10.1016/j.str.2017.12.010openalex-snapshot

Structural Basis for Activity and Specificity of an Anticoagulant Anti-FXIa Monoclonal Antibody and a Reversal Agent

inferred← citeshttps://doi.org/10.1016/j.thromres.2017.06.015openalex-snapshot

Generation and characterization of aptamers targeting factor XIa

inferred← citeshttps://doi.org/10.1016/j.thromres.2017.07.029openalex-snapshot

The role of heparin lead-in in the real-world management of acute venous thromboembolism: The PREFER in VTE registry

inferred← citeshttps://doi.org/10.1016/j.thromres.2018.06.010openalex-snapshot

Fibrinolytic potential of DS-1040, a novel orally available inhibitor of activated thrombin-activatable fibrinolysis inhibitor (TAFIa)

inferred← citeshttps://doi.org/10.1021/acs.jmedchem.0c00464openalex-snapshot

Discovery of a High Affinity, Orally Bioavailable Macrocyclic FXIa Inhibitor with Antithrombotic Activity in Preclinical Species

inferred← citeshttps://doi.org/10.1021/acs.jmedchem.1c02153openalex-snapshot

Targeting the S2 Subsite Enables the Structure-Based Discovery of Novel Highly Selective Factor XIa Inhibitors

inferred← citeshttps://doi.org/10.1021/acs.jmedchem.2c00442openalex-snapshot

Discovery of Potent and Orally Bioavailable Pyridine N-Oxide-Based Factor XIa Inhibitors through Exploiting Nonclassical Interactions

inferred← citeshttps://doi.org/10.1021/acs.jmedchem.2c00845openalex-snapshot

Fluorescent Activity-Based Probe To Image and Inhibit Factor XIa Activity in Human Plasma

inferred← citeshttps://doi.org/10.1021/acs.jmedchem.2c02130openalex-snapshot

Factor XIa Inhibitors in Anticoagulation Therapy: Recent Advances and Perspectives

inferred← citeshttps://doi.org/10.1021/acs.jmedchem.3c00795openalex-snapshot

Design and Preclinical Characterization Program toward Asundexian (BAY 2433334), an Oral Factor XIa Inhibitor for the Prevention and Treatment of Thromboembolic Disorders

inferred← citeshttps://doi.org/10.1021/acs.jmedchem.4c01122openalex-snapshot

An Update on the Nitrogen Heterocycle Compositions and Properties of U.S. FDA-Approved Pharmaceuticals (2013–2023)

inferred← citeshttps://doi.org/10.1021/acs.jmedchem.8b00173openalex-snapshot

Factor XIa Inhibitors as New Anticoagulants

inferred← citeshttps://doi.org/10.1038/nm.4149openalex-snapshot

A rapid pro-hemostatic approach to overcome direct oral anticoagulants

inferred← citeshttps://doi.org/10.1038/s41598-017-02055-xopenalex-snapshot

Selection and characterization of a DNA aptamer inhibiting coagulation factor XIa

inferred← citeshttps://doi.org/10.1038/s41598-017-17508-6openalex-snapshot

Local Production of Activated Factor X in Atherosclerotic Plaque Induced Vascular Smooth Muscle Cell Senescence

inferred← citeshttps://doi.org/10.1038/srep35580openalex-snapshot

Activated Factor X Induces Endothelial Cell Senescence Through IGFBP-5

inferred← citeshttps://doi.org/10.1039/c5ra15430hopenalex-snapshot

Determination of potential main sites of apixaban binding in human serum albumin by combined spectroscopic and docking investigations

inferred← citeshttps://doi.org/10.1055/s-0038-1649507openalex-snapshot

Mechanistic Basis for the Differential Effects of Rivaroxaban and Apixaban on Global Tests of Coagulation

inferred← citeshttps://doi.org/10.1067/j.cpsurg.2015.04.003openalex-snapshot

Update in venous thromboembolism pathophysiology, diagnosis, and treatment for surgical patients

inferred← citeshttps://doi.org/10.1080/03630269.2024.2371884openalex-snapshot

Venous Thromboembolism in Individuals with Sickle Cell Disease: A Narrative Review

inferred← citeshttps://doi.org/10.1080/14779072.2020.1822167openalex-snapshot

Cancer-associated venous thromboembolism and the non-vitamin K antagonist oral anticoagulants: a review of clinical outcomes and patient perspectives

inferred← citeshttps://doi.org/10.1080/14779072.2024.2401865openalex-snapshot

Clinical implications of combination proton pump inhibitor and triple therapies in patients with atrial fibrillation following percutaneous intervention: a guide for clinicians

inferred← citeshttps://doi.org/10.1080/14796678.2024.2343550openalex-snapshot

Delphi consensus on oral anticoagulation management in special clinical situations in the cardiology setting

inferred← citeshttps://doi.org/10.1080/17568919.2024.2409623openalex-snapshot

Selective factor XI/XIa inhibitors: a beacon of hope in anticoagulation therapy

inferred← citeshttps://doi.org/10.1093/ajhp/zxae182openalex-snapshot

Exploring the therapeutic utility of the factor XIa inhibitor asundexian

inferred← citeshttps://doi.org/10.1093/ejcts/ezad340openalex-snapshot

Optimal management of cardiac surgery patients using direct oral anticoagulants: recommendations for clinical practice

inferred← citeshttps://doi.org/10.1093/med/9780199665549.003.0011openalex-snapshot

Haemostasis and thrombosis

inferred← citeshttps://doi.org/10.1093/nar/gkaf571openalex-snapshot

Manipulating DNA and RNA structures via click-to-release caged nucleic acids for biological and biomedical applications

inferred← citeshttps://doi.org/10.1096/fj.201601216ropenalex-snapshot

Avathrin: a novel thrombin inhibitor derived from a multicopy precursor in the salivary glands of the ixodid tick, Amblyomma variegatum

inferred← citeshttps://doi.org/10.1097/fjc.0000000000000770openalex-snapshot

Effects of Rivaroxaban on Platelet Aggregation

inferred← citeshttps://doi.org/10.1097/mbc.0000000000001267openalex-snapshot

Interpreting coagulation mixing study results in the era of direct oral anticoagulants

inferred← citeshttps://doi.org/10.1097/md.0000000000022054openalex-snapshot

Cost-effectiveness of direct oral anticoagulants versus vitamin K antagonist in atrial fibrillation

inferred← citeshttps://doi.org/10.1097/moh.0000000000000369openalex-snapshot

Rendering factor Xa zymogen-like as a therapeutic strategy to treat bleeding

inferred← citeshttps://doi.org/10.1101/2025.08.01.25332685openalex-snapshot

Temporal Patterns of Antithrombotic Therapy and Clinical Outcomes After Atrial Fibrillation-Related Stroke

inferred← citeshttps://doi.org/10.1111/adj.12863openalex-snapshot

Current practices of Western Australian general dentists regarding management of patients on anticoagulant/antiplatelet therapy

inferred← citeshttps://doi.org/10.1111/bcp.15005openalex-snapshot

Wound complications and bleeding with new oral anticoagulants in patients undergoing total joint arthroplasty: A systematic review and meta‐analysis of randomized controlled trials

inferred← citeshttps://doi.org/10.1111/ejh.13471openalex-snapshot

Effectiveness and safety of apixaban and rivaroxaban for acute venous thromboembolism therapy in patients with extremes in bodyweight

inferred← citeshttps://doi.org/10.1111/jth.13747openalex-snapshot

Accuracy and consistency of anti‐Xa activity measurement for determination of rivaroxaban plasma levels

inferred← citeshttps://doi.org/10.1111/jth.15209openalex-snapshot

A novel vitamin K derived anticoagulant tolerant to genetic variations of vitamin K epoxide reductase

inferred← citeshttps://doi.org/10.1111/trf.15259openalex-snapshot

Idarucizumab, but not procoagulant concentrates, fully restores dabigatran‐altered platelet and fibrin components of hemostasis

inferred← citeshttps://doi.org/10.1126/scitranslmed.aaf4331openalex-snapshot

Factor XIa–specific IgG and a reversal agent to probe factor XI function in thrombosis and hemostasis

inferred← citeshttps://doi.org/10.1134/s1070363223150124openalex-snapshot

Anticoagulant Activity of Hybrid Molecules Based on 2,2,4-Trimethyl-4-aryl-1,2,3,4-tetrahydroquinoline and Nitrogen-Containing Heterocycles

inferred← citeshttps://doi.org/10.1136/bmjopen-2017-019161openalex-snapshot

Bleeding risk in patients using oral anticoagulants submitted to surgical procedures in dentistry: a systematic review protocol

inferred← citeshttps://doi.org/10.1136/heartjnl-2020-316914openalex-snapshot

Antithrombotic therapy for patients with chronic coronary syndromes

inferred← citeshttps://doi.org/10.1160/th16-02-0087openalex-snapshot

Treatment of venous thromboembolism with rivaroxaban in relation to body weight

inferred← citeshttps://doi.org/10.1160/th17-02-0108openalex-snapshot

Inducing heat shock protein 70 expression provides a robust anti-thrombotic effect with minimal bleeding risk

inferred← citeshttps://doi.org/10.1161/atvbaha.116.306925openalex-snapshot

Factor XI as a Therapeutic Target

inferred← citeshttps://doi.org/10.1161/atvbaha.118.311655openalex-snapshot

Roles of Coagulation Proteases and PARs (Protease-Activated Receptors) in Mouse Models of Inflammatory Diseases

inferred← citeshttps://doi.org/10.1161/atvbaha.121.317171openalex-snapshot

Direct Oral Anticoagulants and Coronary Artery Disease

inferred← citeshttps://doi.org/10.1161/atvbaha.124.321650openalex-snapshot

Andexanet Alfa–Associated Heparin Resistance in Cardiac Surgery: Mechanism and In Vitro Perspectives

inferred← citeshttps://doi.org/10.1161/jaha.121.022485openalex-snapshot

Termination Based on Event Accrual in Per Protocol Versus Intention to Treat in the ROCKET AF Trial

inferred← citeshttps://doi.org/10.1161/jaha.125.045364openalex-snapshot

Temporal Patterns of Antithrombotic Therapy and Clinical Outcomes After Atrial Fibrillation‐Related Stroke

inferred← citeshttps://doi.org/10.1172/jci.insight.91356openalex-snapshot

Myeloid-related protein-14 regulates deep vein thrombosis

inferred← citeshttps://doi.org/10.1177/1060028016632785openalex-snapshot

Management of Venous Thromboembolism

inferred← citeshttps://doi.org/10.1177/1076029617720067openalex-snapshot

Real-Life Management of Venous Thromboembolism With Rivaroxaban: Results From EXperience VTE, an Italian Epidemiological Survey

inferred← citeshttps://doi.org/10.1177/1076029619847524openalex-snapshot

Factor Xa Inhibitory Profile of Apixaban, Betrixaban, Edoxaban, and Rivaroxaban Does Not Fully Reflect Their Biologic Spectrum

inferred← citeshttps://doi.org/10.1177/17562872251315930openalex-snapshot

Risk of postoperative bleeding and thromboembolic events in anticoagulated patients undergoing transurethral resection of bladder tumors

inferred← citeshttps://doi.org/10.1177/2324709617697991openalex-snapshot

Rivaroxaban as an Antithrombotic Agent in a Patient With ST-Segment Elevation Myocardial Infarction and Left Ventricular Thrombus

inferred← citeshttps://doi.org/10.1186/s12959-017-0129-1openalex-snapshot

The reversal effect of prothrombin complex concentrate (PCC), activated PCC and recombinant activated factor VII against anticoagulation of Xa inhibitor

inferred← citeshttps://doi.org/10.1186/s12959-021-00322-6openalex-snapshot

Bleeding risks with novel oral anticoagulants especially rivaroxaban versus aspirin: a meta-analysis

inferred← citeshttps://doi.org/10.1186/s12959-025-00821-wopenalex-snapshot

Characterization of anticoagulated patients in a Latin American country: indications, treatment patterns, and complications

inferred← citeshttps://doi.org/10.1186/s43044-022-00259-9openalex-snapshot

Switching from warfarin to direct-acting oral anticoagulants: it is time to move forward!

inferred← citeshttps://doi.org/10.1186/s43094-020-00114-1openalex-snapshot

NOACs: an emerging class of oral anticoagulants-a review article

inferred← citeshttps://doi.org/10.1253/circj.cj-15-1017openalex-snapshot

Treating the Unstable Atherosclerotic Plaque by Targeting Activated Factor X – Anticoagulation and Beyond –

inferred← citeshttps://doi.org/10.1308/rcsann.2025.0120openalex-snapshot

Impact of postoperative weight loss on anticoagulant dosing after major lower limb amputation

inferred← citeshttps://doi.org/10.1371/journal.pone.0231565openalex-snapshot

A Delphi consensus on the management of oral anticoagulation in patients with non-valvular atrial fibrillation in Spain: ACOPREFERENCE study

inferred← citeshttps://doi.org/10.1371/journal.pone.0318463openalex-snapshot

Anticoagulants utilization in eight hospitals within the Luzhou region from 2019 to 2023

inferred← citeshttps://doi.org/10.14423/smj.0000000000001372openalex-snapshot

Pharmacologic Agents Used to Reverse the Anticoagulant Effect of Common Anticoagulants

inferred← citeshttps://doi.org/10.15420/ecr.2021.55openalex-snapshot

Role of Direct Oral Anticoagulants for Post-operative Venous Thromboembolism Prophylaxis

inferred← citeshttps://doi.org/10.1556/650.2016.30391openalex-snapshot

Teendők súlyos vérzés vagy sürgős sebészeti beavatkozás esetén direkt orális antikoaguláns gyógyszerrel kezeltekben. Az új dabigatran-antidótum: idarucizumab helye a klinikai gyakorlatban

inferred← citeshttps://doi.org/10.15829/1560-4071-2021-4482openalex-snapshot

Safety and interaction of direct oral anticoagulants with antiarrhythmic drugs

inferred← citeshttps://doi.org/10.15836/ccar2016.351openalex-snapshot

Guidelines on diagnosis, treatment and prevention of venous thrombosis

inferred← citeshttps://doi.org/10.1586/14779072.2015.1069707openalex-snapshot

Is there a need for an alternative in the era of novel anticoagulants?

inferred← citeshttps://doi.org/10.1586/14779072.2015.1096779openalex-snapshot

Evaluating coagulation tests in patients with atrial fibrillation using direct oral anticoagulants

inferred← citeshttps://doi.org/10.17085/apm.2020.15.2.133openalex-snapshot

Perioperative management of patients receiving non-vitamin K antagonist oral anticoagulants: up-to-date recommendations

inferred← citeshttps://doi.org/10.2146/ajhp150959openalex-snapshot

Reversal agents for use with direct and indirect anticoagulants

inferred← citeshttps://doi.org/10.2146/ajhp150966openalex-snapshot

Overview of direct oral anticoagulant therapy reversal

inferred← citeshttps://doi.org/10.2147/iprp.s397844openalex-snapshot

Pharmacy-Led Management of Atrial Fibrillation: Improving Treatment Adherence and Patient Outcomes

inferred← citeshttps://doi.org/10.21542/gcsp.2023.6openalex-snapshot

INVICTUS: Vitamin K antagonists remain the standard of care for rheumatic heart disease-associated atrial fibrillation

inferred← citeshttps://doi.org/10.2174/0113816128309440240427102903openalex-snapshot

Personalized Approaches to Cardiovascular Disease: Insights into FDA-Approved Interventions and Clinical Pharmacogenetics

inferred← citeshttps://doi.org/10.2174/0115748863289321240424063819openalex-snapshot

Herbal Interactions with Cardiac Medications: A Comprehensive Review of Potential Interactions between Herbal Drugs and Commonly Prescribed Cardiac Medications

inferred← citeshttps://doi.org/10.2174/0929867329666220906105200openalex-snapshot

An Overview of Thrombin Inhibitors in the Perspective of Structureactivity Relationships

inferred← citeshttps://doi.org/10.21776/ub.mnj.2023.009.02.11openalex-snapshot

PATTERN OF ANTICOAGULANT THERAPY IN CARDIOEMBOLIC STROKE

inferred← citeshttps://doi.org/10.2210/pdb5qtv/pdbopenalex-snapshot

FACTOR XIA IN COMPLEX WITH THE INHIBITOR methyl [(2R,7S)-7-({(2E)-3-[5-chloro-2-(1H-tetrazol-1-yl)phenyl]prop-2-enoyl}amino)-2-(trifluoromethyl)-2,3,4,5,6,7-hexahydro-1H-8,11-epimino-1,9-benzodiazacyclotridecin-14-yl]carbamate

inferred← citeshttps://doi.org/10.23736/s0026-4725.20.05177-4openalex-snapshot

Non-vitamin K antagonist oral anticoagulants and sport

inferred← citeshttps://doi.org/10.23736/s1593-232x.25.00665-4openalex-snapshot

Rivaroxaban in deep vein thrombosis: an analysis of results in a clinical case series

inferred← citeshttps://doi.org/10.24884/1607-4181-2019-26-3-43-56openalex-snapshot

Safety of direct oral anticoagulants in patients with atrial fibrillation and high risk of stroke (review of literature)

inferred← citeshttps://doi.org/10.25259/sni_608_2022openalex-snapshot

Spontaneous epidural hematoma induced by rivaroxaban: A case report and review of the literature

inferred← citeshttps://doi.org/10.26779/2522-1396.2019.06.73openalex-snapshot

Application of a new peroral anticoagulants in treatment and prophylaxis of thromboembolic complications

inferred← citeshttps://doi.org/10.29413/abs.2019-4.2.3openalex-snapshot

Anticoagulation in Patients with Liver Cirrhosis (Literature Review)

inferred← citeshttps://doi.org/10.30702/ujcvs/23.31(03)/vd041-111126openalex-snapshot

Non-Vitamin K Antagonist Oral Anticoagulants in Differentiated Approach to the Use in Cardiological Practice: Literature Review

inferred← citeshttps://doi.org/10.31590/ejosat.1005114openalex-snapshot

Evaluation Of The Anticoagulant Effect Of Phenolic Extracts Of Two Olive Mill By-products: Olive Mill Wastewater And Olive Mill Pomace

inferred← citeshttps://doi.org/10.3233/jcb-189016openalex-snapshot

Rivaroxaban plasma levels by UPLC-MRM mass spectrometry in a routine laboratory and clinical interpretation

inferred← citeshttps://doi.org/10.3389/fnagi.2022.791285openalex-snapshot

Major Bleeding Risk in Patients With Non-valvular Atrial Fibrillation Concurrently Taking Direct Oral Anticoagulants and Antidepressants

inferred← citeshttps://doi.org/10.3389/fphar.2019.00866openalex-snapshot

Bleeding Risk in Patients Using Oral Anticoagulants Undergoing Surgical Procedures in Dentistry: A Systematic Review and Meta-Analysis

inferred← citeshttps://doi.org/10.3390/diseases13110354openalex-snapshot

The Systemic Link Between Oral Health and Cardiovascular Disease: Contemporary Evidence, Mechanisms, and Risk Factor Implications

inferred← citeshttps://doi.org/10.3390/healthcare14182979openalex-snapshot

Knowledge of Non-Vitamin K Antagonist Oral Anticoagulants and Associated Factors Among Patients with Atrial Fibrillation: A Cross-Sectional Study in Thailand

inferred← citeshttps://doi.org/10.3390/jcm10122693openalex-snapshot

Characteristics, Location, and Clinical Outcomes of Gastrointestinal Bleeding in Patients Taking New Oral Anticoagulants Compared to Vitamin K Antagonists

inferred← citeshttps://doi.org/10.3390/labmed2020010openalex-snapshot

Residual Direct Oral Anticoagulant Activity in the Preoperative Setting: Review of the Literature and a Pilot Study Regarding Direct Oral Anticoagulant Preoperative Interruption (Based on Guidelines) and Its Correlation with Patient Characteristics and Blood Product Transfusion

inferred← citeshttps://doi.org/10.3390/medicina58050691openalex-snapshot

Cutaneous Ulcer Caused by Apixaban Treatment Is Resolved after Replacement with Dabigatran

inferred← citeshttps://doi.org/10.3390/medicina61030425openalex-snapshot

Analysis of Postoperative Bleeding After Oral Surgery in Patients Receiving Anticoagulants: A Retrospective Study

inferred← citeshttps://doi.org/10.3390/molecules25081889openalex-snapshot

Synthesis, Docking, and In Vitro Anticoagulant Activity Assay of Hybrid Derivatives of Pyrrolo[3,2,1-ij]Quinolin-2(1H)-one as New Inhibitors of Factor Xa and Factor XIa

inferred← citeshttps://doi.org/10.3390/molecules30183838openalex-snapshot

Solid-Phase Synthesis for Constructing Thiazolotriazinone-Based Compounds Library

inferred← citeshttps://doi.org/10.3390/nu7115479openalex-snapshot

New Insights into the Pros and Cons of the Clinical Use of Vitamin K Antagonists (VKAs) Versus Direct Oral Anticoagulants (DOACs)

inferred← citeshttps://doi.org/10.4103/0974-8490.181403openalex-snapshot

Effects of Five Bangladeshi Plant Extracts on In vitro Thrombolysis and Cytotoxicity

inferred← citeshttps://doi.org/10.4103/2949-8600.380175openalex-snapshot

Evaluation of the inappropriate prescribing practices of rivaroxaban and their association with bleeding in tertiary care hospitals in Saudi Arabia

inferred← citeshttps://doi.org/10.4103/njm.njm_12_20openalex-snapshot

Anticoagulation in sub-saharan africa with the advent of non-vitamin K antagonist oral anticoagulants

inferred← citeshttps://doi.org/10.4103/sjcp.sjcp_4_23openalex-snapshot

Evaluation of the Inappropriate Prescribing Practices of Rivaroxaban and Their Association with Bleeding in Tertiary Care Hospitals in Saudi Arabia

inferred← citeshttps://doi.org/10.4103/sjmms.sjmms_90_21openalex-snapshot

Effects of Apixaban, Rivaroxaban, Dabigatran and Enoxaparin on Histopathology and Laboratory Parameters in Achilles Tendon Injury

inferred← citeshttps://doi.org/10.4212/cjhp.v70i4.1681openalex-snapshot

Rivaroxaban-Induced Hypersensitivity Syndrome

inferred← citeshttps://doi.org/10.4254/wjh.v7.i29.2906openalex-snapshot

Therapeutic and clinical aspects of portal vein thrombosis in patients with cirrhosis

inferred← citeshttps://doi.org/10.5041/rmmj.10246openalex-snapshot

Effectiveness of Inferior Vena Cava Filters without Anticoagulation Therapy for Prophylaxis of Recurrent Pulmonary Embolism

inferred← citeshttps://doi.org/10.5152/anatoljcardiol.2022.1907openalex-snapshot

Emergency Cardiac Surgery for Acute Type A Aortic Dissection on Apixaban

inferred← citeshttps://doi.org/10.5505/respircase.2023.04764openalex-snapshot

Lupus Anticoagulant Autoantibody Positivity Due to Rivaroxaban: A Case Report

inferred← citeshttps://doi.org/10.5853/jos.2017.02810openalex-snapshot

Heart Failure as a Risk Factor for Stroke

inferred← citeshttps://doi.org/10.6084/m9.figshare.16726954openalex-snapshot

Additional file 1 of Bleeding risks with novel oral anticoagulants especially rivaroxaban versus aspirin: a meta-analysis

inferred← citeshttps://doi.org/10.63845/9bck3p80openalex-snapshot

TRATAMENTO DA TROMBOSE VENOSA PROFUNDA AGUDA COM RIVAROXABANA

inferred← citeshttps://doi.org/10.63845/tjtff568openalex-snapshot

O USO DA RIVAROXABANA COMO MONOTERAPIA NO TRATAMENTO DO TROMBOEMBOLISMO VENOSO BASEADO EM EVIDÊNCIAS

inferred← citeshttps://doi.org/10.7759/cureus.13486openalex-snapshot

A Possible Drug-Drug Interaction Between Eliquis and Amiodarone Resulting in Hemopericardium

inferred← citeshttps://doi.org/10.7759/cureus.30230openalex-snapshot

Safety and Efficacy of Apixaban vs Warfarin in Patients With Stage 4 and 5 Chronic Kidney Disease: A Systematic Review

inferred← citeshttps://doi.org/10.7759/cureus.51089openalex-snapshot

Current Evidence and Expert Opinion on Thromboprophylaxis After Total Knee and Hip Replacement

inferred← citeshttps://doi.org/10.7759/cureus.65835openalex-snapshot

Recent Advances in the Management of Non-rheumatic Atrial Fibrillation: A Comprehensive Review

inferred← citeshttps://doi.org/10.9775/kvfd.2018.19853openalex-snapshot

Yeni Nesil Oral Antikoagulanların İlaç İlaç Etkileşimleri ve Güvenliliğinin Değerlendirilebilmesi İçin Hayvan Modellerinin Geliştirilmesi, Kullanımı ve Bulunabilirliği

Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.